Buy your ticket now and take advantage of the exclusive prices. Go to the ticket office
Do you have a valid invitation code? Go to the pre-registration
GLP-1 drugs are changing how millions of people eat, and food companies are only beginning to measure the impact. This session looks at how appetite-suppressing medications are shifting purchasing patterns, reformulation priorities, and long-term category strategy.
This conference will explore how approaches based on fairness and value chain relationships can complement organic practices by providing concrete responses to challenges that have become central for companies in the food sector: supply chain resilience, value creation, credibility of commitments, and access to increasingly demanding markets.
